Silexion Therapeutics (SLXN) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
60 Degrees Pharmaceuticals is the larger company by market cap ($3.4 million vs $3.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SLXN | SXTP |
|---|---|---|
| Share price | $0.2232 | $0.9774 |
| Market cap | $3.23M | $3.44M |
| 1-day change | -4.98% | +0.50% |
| EPS (TTM) | $-27.21 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $40.70 | $8.62 |
| 52-week low | $0.222 | $0.84 |
| Distance from 52-week high | -99.45% | -88.66% |
| Analyst consensus | none | none |
| Avg. price target upside | +2140.14% | +278.56% |
| Average volume | 9.90M | 130.52K |
| Shares outstanding | 14.47M | 3.52M |
| Employees | 13 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
About 60 Degrees Pharmaceuticals
SXTP stock →60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
SLXN vs SXTP FAQ
Which is bigger, Silexion Therapeutics or 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals (SXTP) is larger, with a market capitalization of $3.44M compared with $3.23M for Silexion Therapeutics (SLXN).
Are Silexion Therapeutics and 60 Degrees Pharmaceuticals in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Silexion Therapeutics and Biotechnology: Pharmaceutical Preparations for 60 Degrees Pharmaceuticals.